AbbVie Inc - Company Profile
Powered by
All the data and insights you need on AbbVie Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date AbbVie Inc Strategy Report
- Understand AbbVie Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on AbbVie Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
HRP20171966T4 | Grant | STABILIZED NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | A61K2800/522; A61K2800/84; A61K38/164; A61K38/48; A61K38/4893; A61K47/02; A61K47/10; A61K47/18; A61K47/183; A61K47/20; A61K47/22; A61K47/26; A61K47/34; A61K8/60; A61K8/66; A61K9/0019; A61K9/08; A61K9/19; A61P13/00; A61P17/00; A61P21/00; A61P25/24; A61P29/00; A61P9/06; A61Q19/00; Y02A50/30 | September 16, 2022 |
HRP20190762T1 | Grant | USE OF PILOCARPINE HYDROCHLORIDE FOR THE TREATMENT OF PRESBYOPIA | A61K31/4178; A61K47/02; A61K47/12; A61K47/186; A61K9/0048; A61P27/02; A61P27/10 | September 16, 2022 |
WO2022132997A9 | Search Report | BICYCLIC PYRAZOLE BRUTON'S TYROSINE KINASE INHIBITORS | C07D471/04; C07D487/04; C07D519/00 | September 15, 2022 |
EP4054585A1 | Application | DOSIERUNGSSCHEMATA ZUR VERWENDUNG BEIM BEHANDELN VON MYELOFIBROSE UND MPN-BEZOGENEN STÖRUNGEN MIT NAVITOCLAX | A61K2300/00; A61K31/519; A61K31/52; A61K31/5377; A61K31/635; A61P35/00; A61P35/02 | September 14, 2022 |
US20220281882A1 | Application | PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF | A61K31/4985; A61K47/12; A61K47/38; A61K9/0053; C07B2200/13; C07D487/14 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward